J&J spreads deal-making net with global ring of satellite offices

John Carroll Johnson & Johnson has been gaining widespread attention for the four big innovation centers it's establishing in key biotech hubs around the world. Now it's ...

Merck to Present New Data, Including Januvia at ADA

mia.burns Merck to Present New Data, Including JANUVIA® (Sitagliptin) and Omarigliptin Data, at the 73rd Scientific Sessions of the American Diabetes Association    Merck (NYSE: ...

NEA’s Mott, Kleiner Perkins pump $20M into cancer drug upstart

John Carroll David Mott at New Enterprise Associates has put together a $ 20 million round to back 3-V Biosciences, an upstart biotech with deep roots in Switzerland's scientific ...

U.K. looks to slash branded drug prices up to 20%

Eric Palmer The U.K. government is the latest to start looking to tamp down prices on already-approved drugs as it tries to take control of what it sees as runaway healthcare ...

The Threat of Self-Insured Plans Among Small Businesses

barbara.lempert Washington, June 19, 2013 — A move by small businesses toward self-insurance schemes could undermine the reforms of the Affordable Care Act and offer fewer protections ...

Report: Theravance CEO shrugs off a soured $1B Elan deal

John Carroll Elan shareholders didn't much care for Kelly Martin's $ 1 billion royalty deal with Theravance. Or any other deals, for that matter, aside from a share buyback. ...

EU grants U.S. API makers exemption from certification rule

Eric Palmer The FDA has gotten the coveted waiver from the European Commission from its new rules for imported APIs less than two weeks before the rule is set to go into effect on July ...

Theravance’s Winningham: The Elan Vote Doesn’t Mean Much

esilverman Over the past few weeks, Theravance has made headlines several times. First, the drugmaker decided to split into two companies – one that will manage respiratory ...

Donald R. Joseph named chief legal officer at KaloBios

Alok Saboo FierceBiotech News

Pfizer’s Viagra patent in Europe expires today

Eric Palmer It's party time in Europe for generic drugmakers. The patent for Pfizer's erectile dysfunction drug Viagra falls off today and generics are expected to soon flood ...

Maine Votes In Favor Importing Drugs From Foreign Pharmacies

esilverman After months of debate over access to affordable medicines, the Maine legislature overwhelmingly voted in favor of a bill that will allow state residents to purchase ...

Takeda asks FDA to OK its potential inflammatory bowel disease blockbuster

John Carroll FierceBiotech News
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS